Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
(St. Jude Reference #)
|Interaction of Reelin With Very Low Density Lipoprotein (VLDL) Receptor (SJ-98-0045)|
|Description||This technology is based on the discovery of the interaction between Reelin and the VLDL receptor. It provides a convenient assay system for receptor binding that is adaptable for screening modulators of the interaction between Reelin and the VLDL receptor or similar receptors. Reelin-signaling underlies the apparent “spread” of the neuropathology across brain networks in patients diagnosed with Alzheimer’s (AD), and could aid in early diagnosis.|
|Keywords||Reelin, VLDL receptor, Alzheimer’s, Neurodegenerative diseases|
|Granted Patents or Published Applications||U.S. Patent No. 6,323,177|
|Related Scientific References||D. Krstic, S. Pfister, T. Notter, I. Knuesel, “Decisive role of Reelin signaling during early stages of Alzheimer’s disease”, Neuroscience 246:108-116 (2013). D'Arcangelo G, et al., “Reelin is a ligand for lipoprotein receptors”, Neuron 24(2):471-9 (1999).|
|Licensing Opportunities||We are currently seeking licensing opportunities in all fields for the development of this technology.|
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.
Last update: June 2013